Literature DB >> 8264648

Functional significance of lysine 1423 of neurofibromin and characterization of a second site suppressor which rescues mutations at this residue and suppresses RAS2Val-19-activated phenotypes.

P Poullet1, B Lin, K Esson, F Tamanoi.   

Abstract

Lysine 1423 of neurofibromin (neurofibromatosis type I gene product [NF1]) plays a crucial role in the function of NF1. Mutations of this lysine were detected in samples from a neurofibromatosis patient as well as from cancer patients. To further understand the significance of this residue, we have mutated it to all possible amino acids. Functional assays using yeast ira complementation have revealed that lysine is the only amino acid that produced functional NF1. Quantitative analyses of different mutant proteins have suggested that their GTPase-activating protein (GAP) activity is drastically reduced as a result of a decrease in their Ras affinity. Such a requirement for a specific residue is not observed in the case of other conserved residues within the GAP-related domain. We also report that another residue, phenylalanine 1434, plays an important role in NF1 function. This was first indicated by the finding that defective NF1s due to an alteration of lysine 1423 to other amino acids can be rescued by a second site intragenic mutation at residue 1434. The mutation partially restored GAP activity in the lysine mutant. When the mutation phenylalanine 1434 to serine was introduced into a wild-type NF1 protein, the resulting protein acquired the ability to suppress activated phenotypes of RAS2Val-19 cells. This suppression, however, does not involve Ras interaction, since the phenylalanine mutant does not stimulate the intrinsic GTPase activity of RAS2Val-19 protein and does not have an increased affinity for Ras proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8264648      PMCID: PMC358429          DOI: 10.1128/mcb.14.1.815-821.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  20 in total

1.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

2.  The neurofibromatosis type 1 gene encodes a protein related to GAP.

Authors:  G F Xu; P O'Connell; D Viskochil; R Cawthon; M Robertson; M Culver; D Dunn; J Stevens; R Gesteland; R White
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

3.  Biological properties of human c-Ha-ras1 genes mutated at codon 12.

Authors:  P H Seeburg; W W Colby; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Nov 1-7       Impact factor: 49.962

4.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.

Authors:  R Ballester; D Marchuk; M Boguski; A Saulino; R Letcher; M Wigler; F Collins
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

5.  The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.

Authors:  G F Xu; B Lin; K Tanaka; D Dunn; D Wood; R Gesteland; R White; R Weiss; F Tamanoi
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

6.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.

Authors:  G A Martin; D Viskochil; G Bollag; P C McCabe; W J Crosier; H Haubruck; L Conroy; R Clark; P O'Connell; R M Cawthon
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

7.  Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway.

Authors:  A M Buchberg; L S Cleveland; N A Jenkins; N G Copeland
Journal:  Nature       Date:  1990-09-20       Impact factor: 49.962

8.  Ras interaction with the GTPase-activating protein (GAP).

Authors:  M D Schaber; V M Garsky; D Boylan; W S Hill; E M Scolnick; M S Marshall; I S Sigal; J B Gibbs
Journal:  Proteins       Date:  1989

9.  IRA2, an upstream negative regulator of RAS in yeast, is a RAS GTPase-activating protein.

Authors:  K Tanaka; B K Lin; D R Wood; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

10.  Interactions between adenylate cyclase and the yeast GTPase-activating protein IRA1.

Authors:  M R Mitts; J Bradshaw-Rouse; W Heideman
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

View more
  14 in total

1.  Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons.

Authors:  James A Walker; Anna V Tchoudakova; Peter T McKenney; Suzanne Brill; Dongyun Wu; Glenn S Cowley; Iswar K Hariharan; André Bernards
Journal:  Genes Dev       Date:  2006-11-17       Impact factor: 11.361

2.  Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles.

Authors:  P Morcos; N Thapar; N Tusneem; D Stacey; F Tamanoi
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

Review 3.  Neurofibromatosis and related tumors. Natural occurrence and animal models.

Authors:  V M Riccardi; J E Womack; T Jacks
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

4.  Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: a molecular modeling and dynamics approach.

Authors:  Ashish Kumar Agrahari; Meghana Muskan; C George Priya Doss; R Siva; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-05-27       Impact factor: 3.584

Review 5.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

6.  Structural analysis of the GAP-related domain from neurofibromin and its implications.

Authors:  K Scheffzek; M R Ahmadian; L Wiesmüller; W Kabsch; P Stege; F Schmitz; A Wittinghofer
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

7.  Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.

Authors:  Frances Hannan; Ivan Ho; James Jiayuan Tong; Yinghua Zhu; Peter Nurnberg; Yi Zhong
Journal:  Hum Mol Genet       Date:  2006-03-02       Impact factor: 6.150

8.  Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation.

Authors:  Ivan Shun Ho; Frances Hannan; Hui-Fu Guo; Inessa Hakker; Yi Zhong
Journal:  J Neurosci       Date:  2007-06-20       Impact factor: 6.167

9.  NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.

Authors:  Alessandro De Luca; Irene Bottillo; Anna Sarkozy; Claudio Carta; Cinzia Neri; Emanuele Bellacchio; Annalisa Schirinzi; Emanuela Conti; Giuseppe Zampino; Agatino Battaglia; Silvia Majore; Maria M Rinaldi; Massimo Carella; Bruno Marino; Antonio Pizzuti; Maria Cristina Digilio; Marco Tartaglia; Bruno Dallapiccola
Journal:  Am J Hum Genet       Date:  2005-10-26       Impact factor: 11.025

10.  Inside and Out.

Authors:  Maximilian F Konig; Vasanth Sathiyakumar; Casey M Phan; Steven P Schulman; Allan C Gelber
Journal:  N Engl J Med       Date:  2021-05-06       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.